Pfizer Inc. buy shadow
Start price
18.11.20
/
50%
€31.40
Target price
18.11.21
-
Performance (%)
45.06%
End price
19.11.21
€45.55
Summary
This prediction ended on 19.11.21 with a price of €45.55. With a performance of 45.06% the BUY prediction by shadow was a big success. A total of €1.31 was paid as dividends for this prediction. shadow has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pfizer Inc. | -1.216% | -1.216% | -34.282% | -26.271% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
According to shadow what are the pros and cons of Pfizer Inc. for the foreseeable future?
Pros
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Growths faster than the competition
Known brand
Future proof or reliable business model
Market Leader or Top 3
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Medium risks for its business
Small cyclical dependencies
Revenue growth > 30% per year expected
Cons
Low dividend yield expected
Few uniques
Sustainability is little important
high free float
Comments by shadow for this prediction
In the thread Pfizer Inc. diskutieren
Buy Pfizer Inc.
In the thread Trading Pfizer Inc.
Die von shadow gewählte maximale Laufzeit wurde überschritten